Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | SPHK1 | Q9NYA1 | 4/20 | 0.39 |
| ▸ | SPHK2 | Q9NRA0 | 3/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2775034 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL9000271 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL2029982 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL3129154 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL2035594 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL7775057 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL7774934 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL2773155 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL1668243 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 | |
| SCHEMBL16551 | 1.00 | ALDH1A1 (0.42) | ALDH1A1TDP1SPHK1SPHK2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 115 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5958869-A | BASIC AMINO-ACID DERIVATIVES OR SALTS THEREOF OBTAINED BY REACTING GLYCIDYL ETHERS WITH BASIC AMINO ACIDS OR SALTS THEREOF | AJINOMOTO CO., INC. (JP) | 1999-09-28 | — | — | US | claimed |
| US-6436536-B1 | — | — | None | — | — | US | disclosed |
| US-20260022104-A1 | AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-22 | — | — | US | disclosed |
| US-20260008901-A1 | AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-01-08 | — | — | US | disclosed |
| US-12404363-B2 | Epoxy resin composition and cured product of same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-09-02 | — | — | US | disclosed |
| EP-4592281-A1 | AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-07-30 | — | — | EP | disclosed |
| EP-4592280-A1 | AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-07-30 | — | — | EP | disclosed |
| US-20250171581-A1 | EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-05-29 | — | — | US | disclosed |
| EP-4516834-A1 | EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-03-05 | — | — | EP | disclosed |
| EP-3693446-B1 | BASE OIL FOR A REFRIGERATING MACHINE OIL, AND WORKING FLUID COMPOSITION FOR REFRIGERATING MACHINES | JX NIPPON OIL & ENERGY CORP (JP) | 2023-11-22 | — | — | EP | disclosed |
| EP-0723985-A1 | Fuel additive | NIPPON OIL CO. LTD. (JP) | 1996-07-31 | — | — | EP | disclosed |
| EP-0717098-A2 | A refrigerating machine oil and a fluid composition for use in a refrigerating machine | NIPPON OIL CO. LTD. (JP) | 1996-06-19 | — | — | EP | disclosed |
| EP-0711824-A2 | Lubricating oil and composition for refrigerating machine, and refrigerating machine | NIPPON OIL CO. LTD. (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0605543-B1 | COMPOSITION FOR EXTERNAL SKIN CARE | KAO CORP (JP) | 1996-03-27 | — | — | EP | disclosed |
| EP-0699742-A2 | Refrigerator oil composition and fluid composition for refrigerator | NIPPON OIL CO. LTD. (JP) | 1996-03-06 | — | — | EP | disclosed |
| EP-0693546-A1 | Refrigerator oil and fluid composition for refrigerator | NIPPON OIL Co. Ltd. (JP) | 1996-01-24 | — | — | EP | disclosed |
| US-5447647-A | Comprise carboxylic esters as base oil and an epoxy compound additive; compatible with new hydrogen containing halocarbons; nonhydrolyzing | NIPPON OIL CO., LTD. (JP) | 1995-09-05 | — | — | US | disclosed |
| EP-0605543-A1 | COMPOSITION FOR EXTERNAL SKIN CARE. | KAO CORP (JP) | 1994-07-13 | — | — | EP | disclosed |
| WO-1993005763-A1 | COMPOSITION FOR EXTERNAL SKIN CARE | KAO CORPORATION (JP) | 1993-04-01 | — | — | WO | disclosed |
| US-4029583-A | GLYCIDYL ETHERS, SILANE COUPLER | PURDUE RESEARCH FOUNDATION (US) | 1977-06-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260022104-A1 | AMINO COMPOUND AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | ASH2L, PRMT1, RER1 | ALDH1A1 982/4885TDP1 3994/4885SPHK1 4734/4885 |
| US-20260008901-A1 | AMINO COMPOSITION AND METHOD FOR PRODUCING SAME, EPOXY RESIN CURING AGENT, AND EPOXY RESIN COMPOSITION AND CURED PRODUCT OF SAME | PRMT1, SRM, BCAT2 | ALDH1A1 514/4885TDP1 2574/4885SPHK1 4300/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.